“A Case Report on Prolonged Response With Trastuzumab Emtansine (T-DM1) in Recurrent Advance Breast Cancer Setting”. Journal of Cancer Research Updates 12 (December 11, 2023): 49–53. Accessed October 22, 2025. https://www.neoplasiaresearch.com/index.php/jcru/article/view/739.